MedTrace Logo

A Study of Methylprednisolone in People Having Liver Surgery

NCT07507643 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 750

Last updated 2026-04-02

No results posted yet for this study

Summary

The purpose of this study is to test whether receiving methylprednisolone before surgery will reduce the side effects of having surgery, such as infections and longer hospital stays.

Conditions

  • Hepatectomy

Interventions

DRUG

Methylprednisolone

single preoperative dose of methylprednisolone

Sponsors & Collaborators

Principal Investigators

  • Michael D'Angelica, MD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-27
Primary Completion
2029-03-27
Completion
2029-03-27
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07507643 on ClinicalTrials.gov